Table 5 Independent effect of gender, age, pre-existing diseases, and symptoms during SARS-CoV-2 infection on Long COVID-19 symptoms in the primary care setting
Response variable | Explanatory variables | OR (95% CI) | p-value |
|---|---|---|---|
Gender (Females vs Males) | 1.18 (0.79–1.76) | 0.421 | |
Age (years) | |||
At least one Long COVID-19 | 0–5 | 1 (reference) | |
symptom | 6–10 | 1.41 (0.84–2.37) | 0.194 |
11–16 | 2.18 (1.31–3.62) | 0.003 | |
(153) | |||
Pre-existing diseases (yes vs no) | 1.11 (0.58–2.12) | 0.746 | |
Symptomatic acute infection (yes vs no) | 6.57 (4.36–9.9) | < 0.001 | |
Gender (Females vs Males) | 1.31 (0.67–2.55) | 0.424 | |
Abnormal fatigue | Age | ||
(44) | 1–5 years | 1 (reference) | |
6–10 | 2.85 (0.87–9.34) | 0.083 | |
11–16 | 7.05 (2.35–21.12) | < 0.001 | |
Pre-existing diseases (yes vs no) | 1.52 (0.62–3.74) | 0.355 | |
Symptomatic acute infection (yes vs no) | 12.22 (5.01–29.78) | < 0.001 | |
Gender (Females vs Males) | 1.67 (0.85–3.24) | 0.132 | |
Age (years) | |||
Neurological symptoms | 1–5 | 1 (reference) | |
(43) | 6–10 | 5.27 (1.47–18.94) | 0.011 |
11–16 | 8.73 (2.54–29.98) | 0.001 | |
Pre-existing diseases (yes vs no) | 0.79 (0.28–2.18) | 0.646 | |
Symptomatic acute infection (yes vs no) | 6.61 (3.13–13.94) | < 0.001 | |
Gender (Females vs Males) | 0.98 (0.5–1.91) | 0.954 | |
Age (years) | |||
Respiratory symptoms | 0–5 | 1 (reference) | |
(38) | 6–10 | 0.32 (0.14–0.72) | 0.006 |
11–16 | 0.23 (0.09–0.58) | 0.002 | |
Pre-existing diseases (yes vs no) | 1.14 (0.32–4.03) | 0.840 | |
Symptomatic acute infection (yes vs no) | 2.11 (1.07–4.13) | 0.030 | |
Gender (Females vs Males) | 1.61 (0.75–3.43) | 0.217 | |
Age (years) | |||
Psychological symptoms | 1–5 | 1 (reference) | |
(31) | 6–10 | 1.28 (0.39–4.16) | 0.682 |
11–16 | 3.79 (1.36–10.52) | 0.011 | |
Pre-existing diseases (yes vs no) | 0.78 (0.22–2.74) | 0.699 | |
Symptomatic acute infection (yes vs no) | 3.08 (1.42–6.67) | 0.004 |